Assembly Biosciences (ASMB) Stock Statistics & Valuation Metrics

Assembly Biosciences has a market cap or net worth of $331.07M. The enterprise value is $66.63M.

Assembly Biosciences has 13,264,101 shares outstanding. The number of shares has decreased by -2.65% in one year.

Assembly Biosciences’s return on equity (ROE) is -1.20 and return on invested capital (ROIC) is -63.76%.

The current PE Ratio of Assembly Biosciences is ―. Assembly Biosciences’s PEG ratio is ―.

In the last 12 months, Assembly Biosciences had revenue of 28.52M and earned -40.18M in profits. Earnings per share was -6.69.

In the last 12 months, operating cash flow was -55.85M and capital expenditures 0.00, giving a free cash flow of -55.85M billion.

Assembly Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Assembly Biosciences upcoming earnings date is Nov 6, 2025, After Close (Confirmed).

Assembly Biosciences as a current ratio of 2.42, with Debt / Equity ratio of 15.93%

In the past 12 months, Assembly Biosciences has paid 330.00K in taxes.

Assembly Biosciences EV to EBITDA ratio is -1.31, with an EV/FCF ratio of -1.16.

Assembly Biosciences has $74.98M in cash and marketable securities with $2.88M in debt, giving a net cash position of -$72.10M billion.

Gross margin is 99.86%, with operating margin of -159.26%, and net profit margin of -140.87%.

The average price target for Assembly Biosciences is $28.33, which is 11.43% higher than the current price. The consensus rating is Moderate Buy